USE OF SIO2 NANOPOWDER AS ADJUVANT FOR PRODUCTION OF ANTIBODIES AGAINST PEPTIDES

USE OF SIO2 NANOPOWDER AS ADJUVANT FOR PRODUCTION OF ANTIBODIES AGAINST PEPTIDES

Invention relates to molecular biology and nanotechnology, in particular to methods for obtaining antibodies against peptides. It is offered to use silica nanopowder as adjuvant and/or carrier for obtaining antibodies. The use of SiO2 nanopowder provides the highest antibody titers with optimal long...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RENHOFA REG NA, STRODS ARNIS, AKOPJANA IN RA, CIEL NS INDULIS, JACKEVI A LUDMILA
Format: Patent
Sprache:eng ; lav
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Invention relates to molecular biology and nanotechnology, in particular to methods for obtaining antibodies against peptides. It is offered to use silica nanopowder as adjuvant and/or carrier for obtaining antibodies. The use of SiO2 nanopowder provides the highest antibody titers with optimal long-term immunity and optimal CD4/CD8 ratio. Izgudrojums attiecas uz molekulāro bioloģiju un nanotehnoloģiju, konkrēti uz paņēmieniem antivielu iegūšanai pret peptīdiem. Tiek piedāvāts par adjuvantu un/vai nesēju antivielu iegūšanai izmantot silīcija dioksīda nanopulveri. SiO2 nanopulvera izmantošana nodrošina visaugstākos antivielu titrus ar visoptimālāko ilglaicīgo imunitāti un optimālu CD4/CD8 attiecību.